Muscular Dystrophy Oculopharyngeal

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-11-25
Clinical Trial Update: Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating autologous myoblast grafts for treating ptosis in oculopharyngeal muscular dystrophy was terminated.